NO864869D0 - Fremgangsmaate for fremstilling av ikke-aromatiske fluorallylamin mao-inhibitorer. - Google Patents

Fremgangsmaate for fremstilling av ikke-aromatiske fluorallylamin mao-inhibitorer.

Info

Publication number
NO864869D0
NO864869D0 NO864869A NO864869A NO864869D0 NO 864869 D0 NO864869 D0 NO 864869D0 NO 864869 A NO864869 A NO 864869A NO 864869 A NO864869 A NO 864869A NO 864869 D0 NO864869 D0 NO 864869D0
Authority
NO
Norway
Prior art keywords
fluorallylamine
aromatic
procedure
preparation
mao inhibitors
Prior art date
Application number
NO864869A
Other languages
English (en)
Other versions
NO165916C (no
NO165916B (no
NO864869L (no
Inventor
Philippe Bey
Ian A Mcdonald
Michael G Palfreyman
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of NO864869D0 publication Critical patent/NO864869D0/no
Publication of NO864869L publication Critical patent/NO864869L/no
Publication of NO165916B publication Critical patent/NO165916B/no
Publication of NO165916C publication Critical patent/NO165916C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00Sulfones; Sulfoxides
    • C07C317/26Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C317/28Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to acyclic carbon atoms of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/62Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/20Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton
    • C07C211/24Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic unsaturated carbon skeleton the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/02Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C217/46Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO864869A 1985-12-05 1986-12-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive, ikke-aromatiske fluorallylamin mao-inhibitorer. NO165916C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/805,506 US4650907A (en) 1985-12-05 1985-12-05 Nonaromatic fluoroallylamine MAO inhibitors

Publications (4)

Publication Number Publication Date
NO864869D0 true NO864869D0 (no) 1986-12-04
NO864869L NO864869L (no) 1987-06-09
NO165916B NO165916B (no) 1991-01-21
NO165916C NO165916C (no) 1991-05-02

Family

ID=25191744

Family Applications (1)

Application Number Title Priority Date Filing Date
NO864869A NO165916C (no) 1985-12-05 1986-12-04 Analogifremgangsmaate for fremstilling av terapeutisk aktive, ikke-aromatiske fluorallylamin mao-inhibitorer.

Country Status (16)

Country Link
US (1) US4650907A (no)
KR (1) KR900006125B1 (no)
CN (1) CN1014515B (no)
AR (1) AR242948A1 (no)
AU (1) AU594722B2 (no)
CA (1) CA1265818C (no)
DK (1) DK167763B1 (no)
FI (1) FI86845C (no)
HU (1) HU199394B (no)
IE (1) IE59058B1 (no)
IL (1) IL80817A (no)
NO (1) NO165916C (no)
NZ (1) NZ218498A (no)
PH (1) PH22545A (no)
PT (1) PT83864B (no)
ZA (1) ZA869057B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965288A (en) * 1988-02-25 1990-10-23 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5059714A (en) * 1988-02-25 1991-10-22 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5252608A (en) * 1988-02-25 1993-10-12 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
AU618076B2 (en) * 1988-02-25 1991-12-12 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyloxidase
US5120764A (en) * 1988-11-01 1992-06-09 Merrell Dow Pharmaceuticals Inc. Inhibitors of lysyl oxidase
US5169868A (en) * 1991-03-01 1992-12-08 University Of Saskatchewan Aliphatic propargylamines as specific mao-b inhibitors
CA2520957C (en) * 2003-03-31 2013-08-06 Sucampo Ag Method for treating vascular hyperpermeable disease
CA2575411A1 (en) * 2004-07-27 2006-02-02 Astellas Pharma Inc. Thiazole derivatives having vap-1 inhibitory activity
EP1791835A2 (en) * 2004-09-09 2007-06-06 Astellas Pharma Inc. Thiazole derivatives having vap-1 inhibitory activity
JP2011504485A (ja) * 2007-11-21 2011-02-10 ファーマクシス リミテッド Ssao/vap−1のハロアリルアミン阻害剤およびその用途
CN107266332B (zh) 2012-05-02 2020-07-24 勃林格殷格翰国际有限公司 Ssao的取代的3-卤代烯丙基胺抑制剂及其用途

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4454158A (en) * 1981-06-01 1984-06-12 Merrell Toraude Et Compagnie Allyl amine MAO inhibitors

Also Published As

Publication number Publication date
CN1014515B (zh) 1991-10-30
CA1265818A (en) 1990-02-13
HUT46293A (en) 1988-10-28
CA1265818C (en) 1990-02-13
FI864962A (fi) 1987-06-06
DK583486D0 (da) 1986-12-04
PT83864B (pt) 1989-01-17
AU6581386A (en) 1987-06-11
IL80817A (en) 1991-06-10
PT83864A (en) 1987-01-01
DK167763B1 (da) 1993-12-13
DK583486A (da) 1987-06-06
FI864962A0 (fi) 1986-12-04
CN86108051A (zh) 1987-08-19
IE59058B1 (en) 1993-12-15
AR242948A1 (es) 1993-06-30
NO165916C (no) 1991-05-02
AU594722B2 (en) 1990-03-15
IL80817A0 (en) 1987-03-31
KR870005960A (ko) 1987-07-08
US4650907A (en) 1987-03-17
NZ218498A (en) 1989-09-27
ZA869057B (en) 1987-07-29
IE863186L (en) 1987-06-05
PH22545A (en) 1988-10-17
HU199394B (en) 1990-02-28
KR900006125B1 (ko) 1990-08-24
NO165916B (no) 1991-01-21
FI86845C (fi) 1992-10-26
FI86845B (fi) 1992-07-15
NO864869L (no) 1987-06-09

Similar Documents

Publication Publication Date Title
NO865013D0 (no) Fremgangsmaate for fremstilling av antibaktercelle kinolon-derivater.
NO165143C (no) Fremgangsmaate til fremstilling av hydrokloridet av fenyl-1-dietylaminokarbonyl-1-aminometyl-2-cyklopropan (z).
NO167569C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzimidazolderivater.
NO863251L (no) Fremgangsmaate for fremstilling av sphingosinderivater.
NO864869D0 (no) Fremgangsmaate for fremstilling av ikke-aromatiske fluorallylamin mao-inhibitorer.
NO861474L (no) Fremgangsmaate ved fremstilling av fenetanolaminderivater.
NO860429L (no) Fremgangsmaate for fremstilling av imidazolyl-indol-derivater.
NO166931C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO863616D0 (no) Fremgangsmaate for fremstilling av n-sulfamyl-3-(2-guanidino-thiazolo-4-yl-methylthio)-propionamid.
NO863343L (no) Fremgangsmaate for fremstilling av gem-dihalo-1,8-diamino-4-aza-octaner.
NO860273L (no) Fremgangsmaate for fremstilling av 4,4-dialkyl-2-azetidinoner.
NO864386L (no) Fremgangsmaate ved fremstilling av uretaner.
NO165538C (no) Fremgangsmaate ved fremstilling av klordioksyd.
NO863769D0 (no) Fremgangsmaate for fremstilling av 4-hydroksy-2-oksopyrrolin-1-yl-acetamid.
NO864087L (no) Fremgangsmaate for fremstilling av aroylthiazoloner.
NO862493L (no) Fremgangsmaate for fremstilling av 2-halonicergolinderivater.
NO863045D0 (no) Fremgangsmaate for fremstilling av alkyl-2-karboalkoksy-3,4-dialkoksybenzenkarbamater.
NO863044D0 (no) Fremgangsmaate for fremstilling av 5,6-dialkoksyantranilsyrer.
IT8620960A0 (it) Procedimento di preparazione di decabromodifeniletere.
FI864790A (fi) Foerfarande foer framstaellning av 5-klor- och 5-brom-2-hydroxinikotinsyror.
NO864305D0 (no) Fremgangsmaate for fremstilling av 5-nafthyl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO861178L (no) Fremgangsmaate for fremstilling av 1,8-nafthyridinoner.
FI864736A (fi) Foerfarande foer framstaellning av 2-substituerade 5-nitroso-4,6-diamino-pyrimidiner.
NO166447C (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomt n-(1-cyclohexenylmethyl-2-pyrrolidinylmethyl)-8-ethylsulfonyl-1,5-benzodioxepan-6-carboxamid.
NO900651L (no) Fremgangsmaate for fremstilling av 2-benzyl-1-nafthol.

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JUNE 2001